4:25-cv-05696 Ascendis Pharma A/S et al v. Biomarin Pharmaceutical Inc.
USCA Mandate ( 83
The US Court of Appeals for the Ninth Circuit has issued a mandate in the case of Ascendis Pharma A/S et al v. Biomarin Pharmaceutical Inc., case number 4:25-cv-05696. This mandate is a formal order from the appeals court to the lower court to take a specific action. The mandate is a result of the appeals court's decision in the case.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Court
Court not identified
Awaiting court metadata
Docket
Not captured
Civil
Stage
Active litigation
Active
Filed
Date unavailable
Not in the available feed
Latest Filing
4:25-cv-05696 Ascendis Pharma A/S et al v. Biomarin Pharmaceutical Inc.
Other · May 04, 2026
Coverage
1 article
1 source tracked
Participants
1 Defendant, 1 Plaintiff
2 linked entities
Judge
Not assigned in feed
The court metadata has not been resolved yet, so Juryvine is keeping the page conservative until a reliable court match lands.
The newest docket activity we have is a other dated May 04, 2026.
The visible party/entity graph currently includes Biomarin Pharmaceutical Inc, 4:25-cv-05696 Ascendis Pharma A/S.
Press monitoring has found 1 related article from 1 distinct source.
The US Court of Appeals for the Ninth Circuit has issued a mandate in the case of Ascendis Pharma A/S et al v. Biomarin Pharmaceutical Inc., case number 4:25-cv-05696. This mandate is a formal order from the appeals court to the lower court to take a specific action. The mandate is a result of the appeals court's decision in the case.
USCA Mandate ( 83
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
3 days, 2 hours ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.